S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 94 900 KRW 0.74% Market Closed
Market Cap: 1.9T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
ST Pharm Co Ltd

Current Assets 348.4B
Cash & Short-Term Investments 90.1B
Receivables 122.6B
Other Current Assets 135.7B
Non-Current Assets 327.1B
Long-Term Investments 17.7B
PP&E 280.1B
Intangibles 13.5B
Other Non-Current Assets 15.7B
Current Liabilities 83.7B
Accounts Payable 17.7B
Accrued Liabilities 8.3B
Short-Term Debt 20.9B
Other Current Liabilities 36.9B
Non-Current Liabilities 207.1B
Long-Term Debt 161.8B
Other Non-Current Liabilities 45.3B

Balance Sheet
ST Pharm Co Ltd

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
2 443
11 804
55 196
72 301
47 709
12 823
38 625
39 203
50 201
50 097
Cash
0
0
0
0
0
12 748
29 921
27 348
50 201
50 097
Cash Equivalents
2 443
11 804
55 196
72 301
47 709
75
8 704
11 855
0
0
Short-Term Investments
0
0
60 000
60 000
60 000
52 216
102 011
54 013
0
40 000
Total Receivables
19 212
16 636
17 968
30 279
17 298
35 951
46 762
64 448
97 871
122 627
Accounts Receivables
15 239
13 234
13 671
30 155
15 737
35 572
45 515
63 248
94 350
121 290
Other Receivables
3 973
3 402
4 297
124
1 561
379
1 247
1 200
3 522
1 336
Inventory
34 961
58 710
91 371
57 975
40 659
40 925
45 401
80 809
107 623
120 736
Other Current Assets
155
8 629
340
4 650
1 632
2 237
2 813
5 668
7 539
14 918
Total Current Assets
56 771
95 779
224 875
225 205
167 299
144 152
235 613
244 142
263 234
348 378
PP&E Net
63 759
134 099
138 430
151 580
169 069
170 980
175 634
210 190
257 885
280 105
PP&E Gross
63 759
134 099
138 430
151 580
169 069
170 980
175 634
210 190
257 885
280 105
Accumulated Depreciation
42 175
47 284
55 900
60 453
68 630
96 349
109 232
116 462
126 187
146 440
Intangible Assets
829
1 092
1 080
1 211
1 407
1 310
1 952
4 164
3 532
3 513
Goodwill
0
0
0
0
0
7 791
8 044
8 455
8 947
9 950
Note Receivable
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
16 185
0
1 037
471
1 059
3 006
7 756
13 264
11 492
17 749
Other Long-Term Assets
4 829
1 397
2 357
3 037
6 671
13 370
16 572
18 351
25 563
15 741
Other Assets
0
0
0
0
0
7 791
8 044
8 455
8 947
9 950
Total Assets
142 373
N/A
232 367
+63%
367 779
+58%
381 504
+4%
345 505
-9%
340 610
-1%
445 570
+31%
498 565
+12%
570 652
+14%
675 436
+18%
Liabilities
Accounts Payable
4 200
10 862
13 689
3 111
3 086
7 164
4 694
12 865
18 095
17 661
Accrued Liabilities
3 840
4 507
4 700
3 078
2 503
2 611
3 097
6 558
9 365
8 264
Short-Term Debt
32 500
32 500
0
0
0
0
0
0
20 000
20 878
Current Portion of Long-Term Debt
38 668
16 475
1 383
20
20
443
894
15 587
95 333
9 372
Other Current Liabilities
3 240
43 884
31 702
22 430
4 345
6 009
9 925
40 355
36 431
27 570
Total Current Liabilities
82 447
108 227
51 473
28 638
9 954
16 227
18 610
75 365
179 224
83 745
Long-Term Debt
176
10 156
137
117
98
15 551
126 033
91 930
19 188
161 832
Minority Interest
0
0
0
0
0
2 387
1 425
3 058
3 471
2 356
Other Liabilities
2 571
3 110
2 924
1 667
3 885
5 622
4 174
5 237
31 138
42 953
Total Liabilities
85 193
N/A
121 493
+43%
54 534
-55%
30 421
-44%
13 936
-54%
39 788
+186%
150 242
+278%
175 591
+17%
233 020
+33%
290 886
+25%
Equity
Common Stock
4 191
5 891
9 242
9 328
9 328
9 328
9 328
9 404
9 404
9 404
Retained Earnings
51 516
76 036
133 994
170 591
151 644
123 561
111 634
115 590
126 893
135 729
Additional Paid In Capital
2 635
26 222
170 032
171 287
171 287
168 725
174 919
195 714
195 747
225 940
Unrealized Security Profit/Loss
1 162
0
69
0
631
823
897
1 011
1 870
1 036
Other Equity
0
2 725
45
123
58
31
344
3 276
7 457
14 513
Total Equity
57 180
N/A
110 874
+94%
313 245
+183%
351 083
+12%
331 569
-6%
300 822
-9%
295 328
-2%
322 974
+9%
337 632
+5%
384 550
+14%
Total Liabilities & Equity
142 373
N/A
232 367
+63%
367 779
+58%
381 504
+4%
345 505
-9%
340 610
-1%
445 570
+31%
498 565
+12%
570 652
+14%
675 436
+18%
Shares Outstanding
Common Shares Outstanding
8
12
18
19
19
19
19
19
19
19
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
0

See Also

Discover More